Originalartikel | erschienen - Druck | peer reviewed
Translating Pharmacological Findings from Hypothyroid Rodents to Euthyroid Humans: Is There a Functional Role of Endogenous 3,5-T2?
THYROID
2015 ;
25(2):
188 - 197
Bibliometrische Indikatoren
Impact Factor = 3,784
Zitierhäufigkeit nach WOS = 25
DOI = 10.1089/thy.2014.0262
PubMed-ID = 25343227
Autoren
Pietzner M*1, Lehmphul I, Friedrich N1, Schurmann C2, Ittermann T3, Dörr M4, Nauck M1, Laqua R5, Laqua R, Völker U2, Brabant G, Völzke H3, Köhrle J, Homuth G2, Wallaschofski H1
Beteiligte Einrichtungen
1 - Institut für Klinische Chemie und Laboratoriumsmedizin
2 - Interfakultäres Institut für Genetik und Funktionelle Genomforschung / Abt. Funktionelle Genomforschung
3 - Institut für Community Medicine / Abt. SHIP KEF
4 - Zentrum für Innere Medizin / Klinik für Innere Medizin B
5 - Zentrum für Radiologie / Institut für Diagnostische Radiologie und Neuroradiologie
Abstract
Background: During the last two decades, it has become obvious that 3,5-diiodothyronine (3,5-T2), a well-known endogenous metabolite of the thyroid hormones thyroxine (T4) or triiodothyronine (T3), not only represents a simple degradation intermediate of the former but also exhibits specific metabolic activities. Administration of 3,5-T2 to hypothyroid rodents rapidly stimulated their basal metabolic rate, prevented high-fat diet-induced obesity as well as steatosis, and increased oxidation of long-chain fatty acids. Objective: The aim of the present study was to analyze associations between circulating 3,5-T2 in human serum and different epidemiological parameters, including age, sex, or smoking, as well as measures of anthropometry, glucose, and lipid metabolism. Methods: 3,5-T2 concentrations were measured by a recently developed immunoassay in sera of 761 euthyroid participants of the population-based Study of Health in Pomerania. Subsequently, analysis of variance and multivariate linear regression analysis were performed. Results: Serum 3,5-T2 concentrations exhibited a right-skewed distribution, resulting in a median serum concentration of 0.24 nM (1st quartile: 0.20 nM; 3rd quartile: 0.37 nM). Significant associations between 3,5-T2 and serum fasting glucose, thyrotropin (TSH), as well as leptin concentrations were detected (p<0.05). Interestingly, the association to leptin concentrations seemed to be mediated by TSH. Age, sex, smoking, and blood lipid profile parameters did not show significant associations with circulating 3,5-T2. Conclusion: Our findings from a healthy euthyroid population may point toward a physiological link between circulating 3,5-T2 and glucose metabolism.
Veröffentlicht in
THYROID
| Jahr | 2015 |
| Impact Factor (2015) | 3,784 |
| Volume | 25 |
| Issue | 2 |
| Seiten | 188 - 197 |
| Open Access | nein |
| Peer reviewed | ja |
| Artikelart | Originalartikel |
| Artikelstatus | erschienen - Druck |
| DOI | 10.1089/thy.2014.0262 |
| PubMed-ID | 25343227 |
Allgemeine Daten zur Fachzeitschrift
Kurzbezeichnung: THYROID
ISSN: 1050-7256
eISSN: 1557-9077
Land: USA
Sprache: English
Kategorie(n):
Impact Factor Entwicklung
ISSN: 1050-7256
eISSN: 1557-9077
Land: USA
Sprache: English
Kategorie(n):
- PERIPHERAL VASCULAR DISEASE
Impact Factor Entwicklung
| Jahr | Impact Factor |
|---|---|
| 2008 | 3 |
| 2009 | 2,602 |
| 2010 | 4,327 |
| 2011 | 4,792 |
| 2012 | 3,544 |
| 2013 | 3,843 |
| 2014 | 4,493 |
| 2015 | 3,784 |
| 2016 | 5,515 |
| 2017 | 7,557 |
| 2018 | 7,786 |
| 2019 | 5,227 |
| 2020 | 6,568 |
| 2021 | 6,506 |
| 2022 | 6,6 |
| 2023 | 5,8 |
| 2024 | 6,7 |
Beteiligte Departments
Community Medicine
Projekte
GANI_MED Teilprojekt PB2 4: Kohorte 4 - Komorbiditäten beim Metabolischen Syndrom
GANI_MED Teilprojekt PB2 1: Kohorte 1 - Kardiovaskuläre Erkrankungen
DZHK: Deutsches Zentrum für Herzkreislaufforschung
GANI_MED Teilprojekt PB2 1: Kohorte 1 - Kardiovaskuläre Erkrankungen
DZHK: Deutsches Zentrum für Herzkreislaufforschung
Departments
Community Medicine
FAQs | Impressum | Datenschutz

